Description
This blend pairs CJC-1295 and Ipamorelin, two peptides frequently studied together in growth-hormone secretagogue research. Preclinical work has characterized CJC-1295 as a GHRH analog and Ipamorelin as a selective ghrelin-receptor agonist; the combination is a common subject in research examining complementary secretagogue pathways. Formulated for researchers investigating these mechanisms in controlled in-vitro models.
Supplied as: Lyophilized powder, sealed vial (CJC-1295 no DAC / Ipamorelin)
Purity: ≥99% per component (HPLC verified)
Testing: Third-party UPLC/MS and LAL per batch
Storage: −20°C, away from light and moisture
Reconstitution: Bacteriostatic water (not included)
For research use only. Not for human or animal administration. Must be handled by a qualified researcher in a licensed laboratory setting. Not approved by the FDA and not intended for diagnostic or therapeutic use.









